Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
The Journal of Experimental Medicine
|
March 8, 2018
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V Menk, Nicole E Scharping, Dayana B Rivadeneira, et al.
The Journal of Clinical Investigation
|
April 21, 2015
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation
Kristen N Pollizzi, Chirag H Patel, Im-Hong Sun, et al.
Oncoimmunology
|
October 24, 2022
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
Konstantinos Lontos, Yiyang Wang, Mason Colbert, et al.
Immunity
|
September 23, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Immunity
|
August 7, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Frontiers in Immunology
|
July 25, 2019
mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells
Alicia R Watson, Helong Dai, Yawen Zheng, et al.
The Journal of Clinical Investigation
|
August 22, 2018
Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted
Jeremy S Tilstra, Lyndsay Avery, Ashley V Menk, et al.
Immunity
|
June 23, 2009
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment
Greg M Delgoffe, Thomas P Kole, Yan Zheng, et al.
Nature Immunology
|
March 2, 2011
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M Delgoffe, Kristen N Pollizzi, Adam T Waickman, et al.
JCI Insight
|
March 18, 2020
NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer
Alexander J Cole, Mangala Iyengar, Santiago Panesso-Gómez, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
The Journal of Experimental Medicine
|
March 8, 2018
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V Menk, Nicole E Scharping, Dayana B Rivadeneira, et al.
The Journal of Clinical Investigation
|
April 21, 2015
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation
Kristen N Pollizzi, Chirag H Patel, Im-Hong Sun, et al.
Oncoimmunology
|
October 24, 2022
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
Konstantinos Lontos, Yiyang Wang, Mason Colbert, et al.
Immunity
|
September 23, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Immunity
|
August 7, 2016
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, et al.
Frontiers in Immunology
|
July 25, 2019
mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells
Alicia R Watson, Helong Dai, Yawen Zheng, et al.
The Journal of Clinical Investigation
|
August 22, 2018
Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted
Jeremy S Tilstra, Lyndsay Avery, Ashley V Menk, et al.
Immunity
|
June 23, 2009
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment
Greg M Delgoffe, Thomas P Kole, Yan Zheng, et al.
Nature Immunology
|
March 2, 2011
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M Delgoffe, Kristen N Pollizzi, Adam T Waickman, et al.
JCI Insight
|
March 18, 2020
NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer
Alexander J Cole, Mangala Iyengar, Santiago Panesso-Gómez, et al.
Page
of 12